Case Letter

Pyoderma Gangrenosum and Tumor Necrosis Factor α Agents

Pyoderma gangrenosum (PG) is a rare, ulcerative, neutrophilic, noninfectious dermatosis of unknown etiology seen in 1% to 5% of patients with inflammatory bowel disease (IBD). It has been reported in all age groups but usually affects women aged 40 to 60 years. Pyoderma gangrenosum often is associated with systemic diseases in approximately 50% of patients affected; however, it is not considered a manifestation or complication of these diseases and its clinical course usually is unrelated to the disease severity or activity.


 

Recommended Reading

What you need to know about health insurance exchanges
MDedge Dermatology
Crusted Scabies and Tinea Corporis After Treatment of Presumed Bullous Pemphigoid
MDedge Dermatology
Nodular Fasciitis: A Possible Side Effect of Etanercept?
MDedge Dermatology
Efinaconazole Solution 10%: Topical Antifungal Therapy for Toenail Onychomycosis
MDedge Dermatology
Product News: 10 2013
MDedge Dermatology
Three simple principles improve procedural safety
MDedge Dermatology
Cosmetic Corner: Dermatologists Weigh in on Men’s Cosmetics
MDedge Dermatology
Looking Forward: Juvéderm Voluma for Midface Volume
MDedge Dermatology
Hives from showering? Think aquagenic urticaria
MDedge Dermatology
Most data reassure regarding TNF inhibitors and cancer
MDedge Dermatology

Related Articles